We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$620M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$242M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$232M
4
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$168M
5
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$137M

Top Sells

Rank Stock Value
1
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$255M
2
SHM icon
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
+$106M
3
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$83.9M
4
ROP icon
Roper Technologies
ROP
+$78.2M
5
USHY icon
iShares Broad USD High Yield Corporate Bond ETF
USHY
+$77M

Sector Composition

Rank Sector Weight
1 Technology 13.07%
2 Healthcare 8.94%
3 Financials 8.8%
4 Industrials 6.53%
5 Consumer Discretionary 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEQ
3451
John Hancock Hedged Equity & Income Fund
HEQ
$141M
$193K ﹤0.01%
16,366
+198
+1% +$2.42K
QJUN icon
3452
FT Vest Growth-100 Buffer ETF June
QJUN
$684M
$193K ﹤0.01%
10,986
-3,125
-22% -$58.7K
TFFP
3453
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$193K ﹤0.01%
1,898
+136
+8% +$18.4K
SLDP icon
3454
Solid Power
SLDP
$548M
$192K ﹤0.01%
36,467
-572
-2% -$3.61K
ARNC
3455
DELISTED
Arconic Corporation
ARNC
$192K ﹤0.01%
11,252
-2,604
-19% -$67.6K
PFD
3456
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$191K ﹤0.01%
17,960
-1,969
-10% -$24.1K
TFSL icon
3457
TFS Financial
TFSL
$4.93B
$191K ﹤0.01%
+14,715
New +$209K
BOOM icon
3458
DMC Global
BOOM
$154M
$190K ﹤0.01%
+11,885
New +$241K
IOVA icon
3459
Iovance Biotherapeutics
IOVA
$2.95B
$190K ﹤0.01%
19,863
+50
+0.3% +$577
MRC
3460
DELISTED
MRC Global
MRC
$189K ﹤0.01%
26,238
+811
+3% +$7.99K
VRT icon
3461
Vertiv
VRT
$111B
$189K ﹤0.01%
19,447
-3,862
-17% -$43.4K
DM
3462
DELISTED
Desktop Metal, Inc.
DM
$189K ﹤0.01%
7,280
+408
+6% +$11.4K
GFI icon
3463
Gold Fields
GFI
$35.4B
$188K ﹤0.01%
23,289
-34,935
-60% -$301K
GGB icon
3464
Gerdau
GGB
$9.4B
$188K ﹤0.01%
52,536
-38,105
-42% -$138K
UEC icon
3465
Uranium Energy
UEC
$5.54B
$185K ﹤0.01%
+52,822
New +$202K
CBAY
3466
DELISTED
Cymabay Therapeutics
CBAY
$183K ﹤0.01%
52,185
-36,527
-41% -$131K
DX
3467
Dynex Capital
DX
$3.23B
$181K ﹤0.01%
15,508
+301
+2% +$4.7K
M icon
3468
Macy's
M
$6.27B
$181K ﹤0.01%
11,541
-669
-5% -$11.8K
BE icon
3469
CALL
Bloom Energy
BE
$69.6B
$180K ﹤0.01%
39,000
-28,300
-42% -$638K
PXLW icon
3470
Pixelworks
PXLW
$46.1M
$179K ﹤0.01%
9,283
– –
BE icon
3471
PUT
Bloom Energy
BE
$69.6B
$178K ﹤0.01%
38,200
-15,000
-28% -$338K
WIA
3472
Western Asset Inflation-Linked Income Fund
WIA
$187M
$178K ﹤0.01%
19,848
-855
-4% -$8.57K
BNY
3473
DELISTED
BlackRock New York Municipal Income Trust
BNY
$177K ﹤0.01%
18,065
– –
HTBK
3474
DELISTED
Heritage Commerce
HTBK
$177K ﹤0.01%
15,603
+1,194
+8% +$13.7K
SEVN
3475
Seven Hills Realty Trust
SEVN
$175M
$176K ﹤0.01%
19,305
-131
-0.7% -$1.37K
137 138
139
140 141

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.